Login / Signup

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

Martin LaussMarco DoniaKatja HarbstRikke AndersenShamik MitraFrida RosengrenMaryem SalimJohan Vallon-ChristerssonTherese TörngrenAnders KvistMarkus RingnérInge Marie SvaneGöran Jönsson
Published in: Nature communications (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Keyphrases
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • randomized controlled trial
  • skin cancer
  • systematic review
  • risk assessment
  • heavy metals